ABBV – AbbVie Inc.
AbbVie is a global, research-based biopharmaceutical company. The company has a portfolio of products that include a broad line of therapies that address some of the world’s most complex and serious diseases. Its primary product is Humira, best known as a rheumatoid arthritis drug; it accounts for some 40% of the company’s total net revenues. Other key products include cancer treatment Imbruvica and hepatitis C drug Mavyret. Products are sold globally, but the US is AbbVie’s largest market, accounting for more than 75% of total sales. In mid-2020, the company completed the acquisition of Allergan.